Related Experiment Videos
Interferon alpha in the therapy of CML
M Talpaz1, H Kantarjian, R Kurzrock
1Department of Clinical Immunology and Biological Therapy, University of Texas Cancer Center, M.D. Anderson Hospital, Houston.
British Journal of Haematology
|October 1, 1991
Abstract:
This paper summarizes the experience with interferon alpha (IFN alpha) as single-agent therapy and in combination gathered at M.D. Anderson Cancer Center. It also covers some of the laboratory research associated with these clinical studies.